CompletedNCT01149577
Olanzapine and Sleep Patterns in Schizophrenia
About this title
Read the official source — NCT01149577Medication studyAges 18–45India
Understand this study
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 45 years. Other eligibility criteria applied.
What did participation involve?
The study group receives olanzapine as a study medication.
- Listed locations
- RanchiSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateAugust 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 25
- Sponsor
- Central Institute of Psychiatry, Ranchi, India
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- India
- Age range
- From 18 Years to 45 Years
- Official registry ID
- NCT01149577
- Official title
Show the full official title
Effect of Olanzapine on Sleep Electroencephalogram (EEG) in Schizophrenia Patients
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Ranchi
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Central Institute of Psychiatry, Ranchi, India, a research institute.
Did this study involve medication?
Yes. The study involved medication, including Olanzapine.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 45 years. Other eligibility criteria applied.
